HUP0600450A2 - Detection of compounds that modulate inflammatory responses - Google Patents
Detection of compounds that modulate inflammatory responsesInfo
- Publication number
- HUP0600450A2 HUP0600450A2 HU0600450A HUP0600450A HUP0600450A2 HU P0600450 A2 HUP0600450 A2 HU P0600450A2 HU 0600450 A HU0600450 A HU 0600450A HU P0600450 A HUP0600450 A HU P0600450A HU P0600450 A2 HUP0600450 A2 HU P0600450A2
- Authority
- HU
- Hungary
- Prior art keywords
- compounds
- detection
- inflammatory responses
- modulate inflammatory
- modulate
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 238000001514 detection method Methods 0.000 title 1
- 230000028709 inflammatory response Effects 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
- G01N33/6869—Interleukin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25930600P | 2000-12-29 | 2000-12-29 | |
| PCT/US2001/050818 WO2002066978A2 (en) | 2000-12-29 | 2001-12-21 | Detection of compounds that modulate inflammatory responses |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUP0600450A2 true HUP0600450A2 (en) | 2006-09-28 |
Family
ID=22984398
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0600450A HUP0600450A2 (en) | 2000-12-29 | 2001-12-21 | Detection of compounds that modulate inflammatory responses |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7273712B2 (hu) |
| EP (1) | EP1368648A2 (hu) |
| JP (1) | JP2005501222A (hu) |
| BR (1) | BR0116606A (hu) |
| CA (1) | CA2433348A1 (hu) |
| HU (1) | HUP0600450A2 (hu) |
| IL (1) | IL156651A0 (hu) |
| IS (1) | IS6861A (hu) |
| NO (1) | NO20032986L (hu) |
| PL (1) | PL366250A1 (hu) |
| WO (1) | WO2002066978A2 (hu) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA200300442A1 (ru) * | 2000-10-02 | 2003-10-30 | Редди Ю Эс Терапьютикс, Инк. | Способы и композиции для лечения воспалительных заболеваний |
| PL366250A1 (en) * | 2000-12-29 | 2005-01-24 | Reddy Us Therapeutics, Inc. | Detection of compounds that modulate inflammatory responses |
| CN1774445A (zh) * | 2002-08-16 | 2006-05-17 | 惠氏公司 | 用于治疗rage相关病症的组合物和方法 |
| WO2005040163A1 (en) * | 2003-10-28 | 2005-05-06 | Dr. Reddy's Laboratories Ltd | Heterocyclic compounds that block the effects of advanced glycation end products (age) |
| KR20070057818A (ko) * | 2004-08-03 | 2007-06-07 | 트랜스테크 파르마, 인크. | Ｒａｇｅ 융합 단백질 및 이의 사용 방법 |
| EP1781700B1 (en) | 2004-08-03 | 2014-03-19 | TransTech Pharma, LLC | Rage fusion proteins and methods of use |
| US20060084184A1 (en) * | 2004-10-19 | 2006-04-20 | Renovar Incorporated | Reagents for urine-based immunological assays |
| ES2431632T3 (es) * | 2005-12-23 | 2013-11-27 | Gcoder Systems Ab | Patrón de posicionamiento |
| ES2431291T3 (es) | 2006-01-10 | 2013-11-25 | Colgate-Palmolive Company | Métodos para modular receptores de superficie celular para prevenir o reducir la inflamación |
| US20090004190A1 (en) * | 2006-02-09 | 2009-01-01 | Mjalli Adnan M M | Rage Fusion Proteins And Methods Of Use |
| EP2380983A3 (en) * | 2006-05-05 | 2012-12-05 | TransTech Pharma Inc. | RAGE fusion proteins, formulations, and methods of use thereof |
| WO2008100470A2 (en) * | 2007-02-15 | 2008-08-21 | Transtech Pharma, Inc. | Rage - immunoglobulin fusion proteins |
| JP5706688B2 (ja) | 2007-06-14 | 2015-04-22 | ギャラクティカ ファーマシューティカルズ， インク． | Ｒａｇｅ融合タンパク質 |
| WO2009063307A2 (en) * | 2007-11-14 | 2009-05-22 | Bio-Technology General (Israel) Ltd. | Inflammatory activity detection method using il-6 |
| WO2010122460A1 (en) | 2009-04-20 | 2010-10-28 | Pfizer Inc. | Control of protein glycosylation and compositions and methods relating thereto |
| EP2678360A1 (en) * | 2011-02-21 | 2014-01-01 | Fibrostatin, S.L. | Methods for treating and diagnosing disease |
| US20160077107A1 (en) * | 2013-05-02 | 2016-03-17 | Stichting Katholieke Universiteit | Personalised medicine |
| WO2016123163A2 (en) | 2015-01-27 | 2016-08-04 | Kardiatonos, Inc. | Biomarkers of vascular disease |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5807884A (en) * | 1992-10-30 | 1998-09-15 | Emory University | Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
| US6340459B1 (en) * | 1995-12-01 | 2002-01-22 | The Trustees Of Columbia University In The City Of New York | Therapeutic applications for the anti-T-BAM (CD40-L) monoclonal antibody 5C8 in the treatment of reperfusion injury in non-transplant recipients |
| EA200300442A1 (ru) * | 2000-10-02 | 2003-10-30 | Редди Ю Эс Терапьютикс, Инк. | Способы и композиции для лечения воспалительных заболеваний |
| PL366250A1 (en) * | 2000-12-29 | 2005-01-24 | Reddy Us Therapeutics, Inc. | Detection of compounds that modulate inflammatory responses |
| US7173032B2 (en) * | 2001-09-21 | 2007-02-06 | Reddy Us Therapeutics, Inc. | Methods and compositions of novel triazine compounds |
-
2001
- 2001-12-21 PL PL01366250A patent/PL366250A1/xx unknown
- 2001-12-21 CA CA002433348A patent/CA2433348A1/en not_active Abandoned
- 2001-12-21 WO PCT/US2001/050818 patent/WO2002066978A2/en not_active Application Discontinuation
- 2001-12-21 EP EP01998128A patent/EP1368648A2/en not_active Withdrawn
- 2001-12-21 US US10/026,335 patent/US7273712B2/en not_active Expired - Fee Related
- 2001-12-21 JP JP2002566653A patent/JP2005501222A/ja active Pending
- 2001-12-21 HU HU0600450A patent/HUP0600450A2/hu unknown
- 2001-12-21 BR BRPI0116606-9A patent/BR0116606A/pt unknown
- 2001-12-21 IL IL15665101A patent/IL156651A0/xx unknown
-
2003
- 2003-06-26 IS IS6861A patent/IS6861A/is unknown
- 2003-06-27 NO NO20032986A patent/NO20032986L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IL156651A0 (en) | 2004-01-04 |
| BR0116606A (pt) | 2006-05-09 |
| JP2005501222A (ja) | 2005-01-13 |
| NO20032986D0 (no) | 2003-06-27 |
| IS6861A (is) | 2003-06-26 |
| PL366250A1 (en) | 2005-01-24 |
| EP1368648A2 (en) | 2003-12-10 |
| CA2433348A1 (en) | 2002-08-29 |
| US20020086282A1 (en) | 2002-07-04 |
| WO2002066978A3 (en) | 2003-01-23 |
| NO20032986L (no) | 2003-08-13 |
| WO2002066978A2 (en) | 2002-08-29 |
| US7273712B2 (en) | 2007-09-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0600450A2 (en) | Detection of compounds that modulate inflammatory responses | |
| AU8356201A (en) | Ultra-sensitive detection systems | |
| ID27280A (id) | Inhibitor-inhibitor dari enzim-enzim fosfolipase | |
| DE60117640D1 (de) | Abgeschirmter Verbinder | |
| AR028253A1 (es) | Inhibidores de la glucogeno fosforilasa | |
| IL137540A0 (en) | Inhibitors of phospholipase a2 | |
| DE19983276T1 (de) | Festkörpertransformator | |
| AU4217201A (en) | Tri-aryl-substituted-ethane pde4 inhibitors | |
| HK1038796B (zh) | 接地電阻的測試方法 | |
| GB0121562D0 (en) | Surface potential detection apparatus | |
| GB2372568B (en) | Seismic detection | |
| AU2001267823A1 (en) | Compounds exhibiting x-type spla2 inhibiting effect | |
| AU4289201A (en) | Device for measuring of friction | |
| DE60003279D1 (de) | Abgeschirmter Verbinder | |
| GB0126267D0 (en) | Repeater detection | |
| DE60137744D1 (de) | Aufzeichnungsgerät | |
| GB0026465D0 (en) | Quantifying the effectiveness of an inspection procedure | |
| AU1414702A (en) | Detection of allergen-associated materials | |
| DE60123325D1 (de) | Abgeschirmter Verbinder | |
| AUPR195900A0 (en) | Detection of compounds such as thyroxine | |
| GB0023439D0 (en) | Detection of fluoride | |
| GB0007778D0 (en) | Detection of brain damage | |
| FR2803388B1 (fr) | Connecteur de test | |
| HU1943U (en) | Testing device for determination of pavement boughness | |
| AU2002223742A1 (en) | Apparatus for parallel detection of the behaviour of mechanical micro-oscillators |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees |